InsidersTradesSigma
Follow the 以岭药业 share price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 以岭药业 has published 3 insider filings. Market capitalisation: €27.6bn. The latest transaction was reported on 5 May 2023 (Sale). Among the most active insiders: 张秋莲. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Yiling Pharmaceutical is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research and development of traditional Chinese and modern medicines.